U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

April 19, 2017

"What is truly exciting is that the National Institutes of Health at www.clinicaltrials now lists clinical trials ongoing at such prestigious research institutions as Duke University and Memorial Sloan-Kettering Cancer Center to understand the possible usage of stem cell infusions for the treatment of intractable diseases, including Type I diabetes in children, cerebral palsy in children, chronic spinal cord injuries, lymphoma and other blood borne cancers," Mr. Schissler said.

"Also, there is research ongoing elsewhere in the world to use umbilical cord blood stem cells to combat Alzheimer's, cardiac disease, lupus, multiple sclerosis, muscular dystrophy, Parkinson's Disease, rheumatoid arthritis and stroke.  This truly is an excellent time to be involved in this sector as we work toward our goal of becoming the most significant stem cell company in the world," said Mr. Schissler.

SOURCE Cord Blood America, Inc.